Researchers from Clínic-IDIBAPS have participated in a study published in Nature Reviews Cancer that reviews how fat-associated liver diseases, kno...
The Liver Vascular Biology research group ubicated at Esther Koplowitz Centre at IDIBAPS has led a scientific review that compiles and analyzes the...
A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded by the Horizon 2020 programme (847989) has published the firs...
Metabolic fatty liver disease affects almost 30% of the population, and 80% of those who are obese. The disease has no cure, but its progression ca...
One in four people have fatty liver; a condition that can be reversed with a healthy lifestyle. The nurse, Marta Cervera, explains 5 recommendation...
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deteriorat...
IDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver...
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surv...
A study published in the journal Nature Medicine proposes a paradigm shift in the approach to steatohepatitis, the most advanced degree of non-alco...
